Endovascular therapy is an area of intense investigation and recent data showing the benefits of this therapy for stroke represent a paradigm shift. This educational activity will feature the results of several randomized clinical trials comparing the administration of tissue plasminogen activator (tPA) followed by device removal of a clot with IV tPA alone and how to identify which patients may benefit from endovascular therapy. Experts will also touch upon the implications of these trials on emergency medical services and how we may optimize institutional systems of care for better patient outcomes.
INTENDED AUDIENCE
Interventional Neuroradiologists, Neurologists, Interventional Neurologists, Neurosurgeons, Nurses, Neurointensive Care Nurses, Radiology Technicians
This webcast offers 1.25 credits. It expires July 1, 2016.
To take the course, click here or go to mycme.com
